BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1724464)

  • 1. Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage.
    Martel-Pelletier J; Faure MP; McCollum R; Mineau F; Cloutier JM; Pelletier JP
    J Rheumatol; 1991 Dec; 18(12):1863-71. PubMed ID: 1724464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
    Hilal G; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
    Arthritis Rheum; 1999 Oct; 42(10):2112-22. PubMed ID: 10524682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
    Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G; Serni U; Matucci A; Mannoni A; Pucci M; Anichini E; Del Rosso M
    J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
    Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
    J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis.
    Pelletier JP; Mineau F; Faure MP; Martel-Pelletier J
    Arthritis Rheum; 1990 Oct; 33(10):1466-76. PubMed ID: 2171538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of plasminogen activator activity in arthritic joints.
    Hamilton JA; Hart PH; Leizer T; Vitti GF; Campbell IK
    J Rheumatol Suppl; 1991 Feb; 27():106-9. PubMed ID: 1902874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues.
    Span PN; Witjes JA; Grebenchtchikov N; Geurts-Moespot A; Moonen PM; Aalders TW; Vriesema JL; Kiemeney LA; Schalken JA; Sweep FC
    BJU Int; 2008 Jul; 102(2):177-82. PubMed ID: 18336603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
    J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.
    Niedbala MJ; Sartorelli AC
    Cancer Commun; 1990; 2(5):189-99. PubMed ID: 2142433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of collagenase 3 in human osteoarthritic cartilage by activation of extracellular transforming growth factor beta: role of furin convertase.
    Moldovan F; Pelletier JP; Mineau F; Dupuis M; Cloutier JM; Martel-Pelletier J
    Arthritis Rheum; 2000 Sep; 43(9):2100-9. PubMed ID: 11014362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.
    Sitrin RG; Gyetko MR; Kole KL; McKeever P; Varani J
    Cancer Res; 1990 Aug; 50(16):4957-61. PubMed ID: 2379161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.